Skip to content

Public FDA record

Z-0223-2025: A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (

Recall record Z-0223-2025 for Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0223-2025
Company in FDA record
Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.
FDA classification date
Oct 24, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.

Source facts

Action
PTS Diagnostics issued Urgent Medical Device Recall letter on 9/18/24 via UPS or Email. Letter states reason for recall, health risk and action to take: 1. Return any product remaining in your control for replacement. 2. Distributors should immediately forward this notice and response form to all customers/users who may have received this product. 3. Acknowledge receipt of this instruction by completing the attached form, even if you do not have the affected product on hand. PTS would like to remind customers/distributors that professional use products are prescription use only in the United States, meaning that federal law restricts this device to sale by or on the order of a licensed healthcare professional. We highly encourage you to monitor the activities of your customers/resel lers. Actions that have been taken by PTS Diagnostics: PTS Diagnostics has investigated this al legation and cannot confirm its veracity based on our review of retention samples, batch records, or product on hand Because the customers purchased these products through an e-tailer/reseller, PTS does not know if the issue could have happened in the distribution channel. Contact Information: Thank you for your prompt action, and we apologize for any inconvenience this issue may have caused you and your facility. If you have any questions, please contact Customer Service directly, Monday through Friday, 8:00 AM to 5:00 PM, Eastern Time at + 1 317-870-5610 or 877-870-5610 (U.S. toll-free).
Initiated
2024-09-18
Root cause
Under Investigation by firm
Distribution
Worldwide distribution - US Nationwide and the countries of Japan, South Africa.
Recall number
Z-0223-2025
Recall status
Completed
CDRH record ID
210203
FDA classified
2024-10-24
Recall event number
95416

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗